CV Sciences Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 44

Employees

  • Stock Symbol
  • CVSI

Stock Symbol

  • Investments
  • 5

CV Sciences General Information

Description

CV Sciences Inc is a consumer wellness company specializing in nutraceuticals and plant-based foods products. It develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The company sells its products under tradenames, such as +PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox. The company's products are sold in a variety of market sectors, including nutraceutical, beauty care, and specialty foods. The company has one operating segment, which is the business of hemp-based CBD wellness products. Geographically, all of the company's revenue is generated from United States. The company also operates a drug development program focused on developing and commercializing CBD-based novel therapeutics.

Contact Information

Formerly Known As
Foreclosure Solutions, CannaVest, Cannavest Corp., Foreclosure Solutions, Inc.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 9530 Padgett Street
  • Suite 107
  • San Diego, CA 92126
  • United States
+1 (800)
Primary Industry
Drug Discovery
Other Industries
Distributors (Healthcare)
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 9530 Padgett Street
  • Suite 107
  • San Diego, CA 92126
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CV Sciences Stock Performance

As of 13-Nov-2026, CV Sciences’s current market cap is $2.03M with 226M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.03M 226M 699K -$0.01

CV Sciences Financials Summary

As of 30-Jun-2026, CV Sciences has a trailing 12-month revenue of $12.7M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 6,138 12,297 6,084 4,291
Revenue 12,743 13,789 15,705 16,004
EBITDA (1,572) (240) (1,856) 3,331
Net Income (2,006) (958) (2,394) 3,102
Total Assets 6,521 6,962 7,927 9,200
Total Debt 1,253 1,609 779 442
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CV Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CV Sciences‘s full profile, request access.

Request a free trial

CV Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
CV Sciences Inc is a consumer wellness company specializing in nutraceuticals and plant-based foods products. It develop
Drug Discovery
San Diego, CA
44 As of 2025

Louisville, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CV Sciences Competitors (1)

One of CV Sciences’s competitors is Charlotte's Web, a Formerly VC-backed company based in Louisville, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charlotte's Web Formerly VC-backed Louisville, CO
You’re viewing 1 of 1 competitors. Get the full list »

CV Sciences Patents

CV Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017267927-A1 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction Active 16-May-2016
AU-2017267927-B2 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction Inactive 16-May-2016
AU-2020256349-A1 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction Active 16-May-2016
AU-2020256349-B2 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction Inactive 16-May-2016
CA-3021835-A1 Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction Active 16-May-2016 A61K31/658
To view CV Sciences’s complete patent history, request access »

CV Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CV Sciences Investments & Acquisitions (5)

CV Sciences’s most recent deal was a Merger/Acquisition with Extract Labs for . The deal was made on 21-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Extract Labs 21-Nov-2024 Merger/Acquisition Other Consumer Non-Durables
Elevated Softgels 13-May-2024 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Cultured Foods 07-Dec-2023 Merger/Acquisition Food Products
CanX (Drug Discovery) 04-Jan-2016 Merger/Acquisition Drug Discovery
Neuropathix 07-Mar-2013 Early Stage VC Drug Discovery
To view CV Sciences’s complete investments and acquisitions history, request access »

CV Sciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Household Products

Industry

Rank

Percentile

Personal Products

Subindustry

Rank

Percentile

To view CV Sciences’s complete esg history, request access »

CV Sciences Exits (1)

CV Sciences’s most recent exit was on 07-Mar-2013 from Neuropathix. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Neuropathix 07-Mar-2013 Completed
  • 2 buyers
To view CV Sciences’s complete exits history, request access »

CV Sciences Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Cultured Foods Puławy, Poland 2019
Elevated Softgels Grand Junction, CO 2019

CV Sciences FAQs

  • When was CV Sciences founded?

    CV Sciences was founded in 2010.

  • Where is CV Sciences headquartered?

    CV Sciences is headquartered in San Diego, CA.

  • What is the size of CV Sciences?

    CV Sciences has 44 total employees.

  • What industry is CV Sciences in?

    CV Sciences’s primary industry is Drug Discovery.

  • Is CV Sciences a private or public company?

    CV Sciences is a Public company.

  • What is CV Sciences’s stock symbol?

    The ticker symbol for CV Sciences is CVSI.

  • What is the current market cap of CV Sciences?

    The current market capitalization of CV Sciences is $2.03M.

  • What is CV Sciences’s current revenue?

    The trailing twelve month revenue for CV Sciences is $12.7M.

  • Who are CV Sciences’s competitors?

    Charlotte's Web is a competitor of CV Sciences.

  • What is CV Sciences’s annual earnings per share (EPS)?

    CV Sciences’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process